Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dr Reddys Laboratories ADR repsg 1 Ord Shs RDY

Healthcare
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The... see more

Recent & Breaking News (NYSE:RDY)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Ltd.

PR Newswire November 10, 2015

Statement from Dr. Reddy's Regarding the Receipt of Temporary Restraining Order (TRO) for Esomeprazole Capsules

Business Wire November 10, 2015

SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against Dr. Reddy's Laboratories Ltd. and Strongly Encourages Investors to Contact the Firm

Business Wire November 9, 2015

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Dr. Reddy's Laboratories Ltd. - RDY

Business Wire November 9, 2015

Law Offices of Howard G. Smith Commences Investigation on Behalf of Dr. Reddy's Laboratories, Ltd. Investors

Business Wire November 9, 2015

Dr. Reddy's ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Dr. Reddy's Laboratories; Encourages Investors to Contact the Firm

Business Wire November 6, 2015

Dr. Reddy's to Hold a Conference Call on Nov 9, 2015 at 4.00 PM IST / 5.30 AM EST

Business Wire November 6, 2015

Dr. Reddy's Statement on the Receipt of Warning Letter from US FDA

Business Wire November 6, 2015

Biocodex Inks Distribution Pact with Dr. Reddy's to Market Its Flagship Products in Romania

Business Wire November 4, 2015

Dr. Reddy's Strengthens OTC Portfolio - Launches Nise D Spray

Business Wire November 2, 2015

Dr. Reddy's Q2 and H1 FY16 Financial Results

Business Wire October 29, 2015

Dr. Reddy's to Release Q2FY16 Results on Oct 29, 2015 // Earnings Call Slated for Oct 29, 6.30 PM IST / 9.00 AM EDT

Business Wire October 19, 2015

Dr. Reddy's Announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg

Business Wire September 28, 2015

Dr. Reddy's Laboratories Signs Commercialization Deal with Hatchtech

Business Wire September 14, 2015

PanTheryx and Dr. Reddy's Announce an Agreement to Market PanTheryx's Proprietary Nutritional Intervention for Pediatric Infectious Diarrhea

Business Wire September 9, 2015

Dr. Reddy's Announces Management Changes

Business Wire August 27, 2015

Dr. Reddy's Announces the Launch of PRAMIPEXOLE Dihydrochloride Extended-Release Tablets

Business Wire August 12, 2015

Dr. Reddy's Announces Strategic Collaboration with Amgen in India

Business Wire August 6, 2015

Dr. Reddy's Q1 FY16 Financial Results

Business Wire July 30, 2015

Dr. Reddy's to Release Q1FY16 Results on July 30, 2015 // Earnings Call Slated for July 30, 6.30 PM IST / 9.00 AM EDT

Business Wire July 23, 2015